Press Releases from Biomay AG (1 total)
Biomay AG: Allergy Vaccine Successful
Biomay, a global leader in allergy immunotherapy, announced today that a second Phase IIb study (clinicaltrials.gov identifier NCT02643641) has been successfully completed with its third…
Go To Page:
